» Articles » PMID: 27758873

Systems Analysis Uncovers Inflammatory Th/Tc17-driven Modules During Acute GVHD in Monkey and Human T Cells

Abstract

One of the central challenges of transplantation is the development of alloreactivity despite the use of multiagent immunoprophylaxis. Effective control of this immune suppression-resistant T-cell activation represents one of the key unmet needs in the fields of both solid-organ and hematopoietic stem cell transplant (HCT). To address this unmet need, we have used a highly translational nonhuman primate (NHP) model to interrogate the transcriptional signature of T cells during breakthrough acute graft-versus-host disease (GVHD) that occurs in the setting of clinically relevant immune suppression and compared this to the hyperacute GVHD, which develops in unprophylaxed or suboptimally prophylaxed transplant recipients. Our results demonstrate the complex character of the alloreactivity that develops during ongoing immunoprophylaxis and identify 3 key transcriptional hallmarks of breakthrough acute GVHD that are not observed in hyperacute GVHD: (1) T-cell persistence rather than proliferation, (2) evidence for highly inflammatory transcriptional programming, and (3) skewing toward a T helper (Th)/T cytotoxic (Tc)17 transcriptional program. Importantly, the gene coexpression profiles from human HCT recipients who developed GVHD while on immunosuppressive prophylactic agents recapitulated the patterns observed in NHP, and demonstrated an evolution toward a more inflammatory signature as time posttransplant progressed. These results strongly implicate the evolution of both inflammatory and interleukin 17-based immune pathogenesis in GVHD, and provide the first map of this evolving process in primates in the setting of clinically relevant immunomodulation. This map represents a novel transcriptomic resource for further systems-based efforts to study the breakthrough alloresponse that occurs posttransplant despite immunoprophylaxis and to develop evidence-based strategies for effective treatment of this disease.

Citing Articles

Pathophysiology and preclinical relevance of experimental graft-versus-host disease in humanized mice.

Ehx G, Ritacco C, Baron F Biomark Res. 2024; 12(1):139.

PMID: 39543777 PMC: 11566168. DOI: 10.1186/s40364-024-00684-9.


The graft versus leukemia effect: donor lymphocyte infusions and cellular therapy.

Maurer K, Antin J Front Immunol. 2024; 15:1328858.

PMID: 38558819 PMC: 10978651. DOI: 10.3389/fimmu.2024.1328858.


Notch signaling drives intestinal graft-versus-host disease in mice and nonhuman primates.

Tkachev V, Vanderbeck A, Perkey E, Furlan S, McGuckin C, Gomez Atria D Sci Transl Med. 2023; 15(702):eadd1175.

PMID: 37379368 PMC: 10896076. DOI: 10.1126/scitranslmed.add1175.


Milestones in acute GVHD pathophysiology.

Socie G, Michonneau D Front Immunol. 2022; 13:1079708.

PMID: 36544776 PMC: 9760667. DOI: 10.3389/fimmu.2022.1079708.


Engineering T cells to suppress acute GVHD and leukemia relapse after allogeneic hematopoietic stem cell transplantation.

Mo F, Watanabe N, Omdahl K, Burkhardt P, Ding X, Hayase E Blood. 2022; 141(10):1194-1208.

PMID: 36044667 PMC: 10023730. DOI: 10.1182/blood.2022016052.


References
1.
Maher K, Konjar S, Watts C, Turk B, Kopitar-Jerala N . Cystatin F regulates proteinase activity in IL-2-activated natural killer cells. Protein Pept Lett. 2014; 21(9):957-65. DOI: 10.2174/0929866521666140403124146. View

2.
Zhou A, El Hed A, Mercer F, Kozhaya L, Unutmaz D . The metalloprotease ADAM12 regulates the effector function of human Th17 cells. PLoS One. 2013; 8(11):e81146. PMC: 3867213. DOI: 10.1371/journal.pone.0081146. View

3.
McDonald-Hyman C, Turka L, Blazar B . Advances and challenges in immunotherapy for solid organ and hematopoietic stem cell transplantation. Sci Transl Med. 2015; 7(280):280rv2. PMC: 4425354. DOI: 10.1126/scitranslmed.aaa6853. View

4.
Wei G, Wei L, Zhu J, Zang C, Hu-Li J, Yao Z . Global mapping of H3K4me3 and H3K27me3 reveals specificity and plasticity in lineage fate determination of differentiating CD4+ T cells. Immunity. 2009; 30(1):155-67. PMC: 2722509. DOI: 10.1016/j.immuni.2008.12.009. View

5.
Zhou Q, Amar S . Identification of signaling pathways in macrophage exposed to Porphyromonas gingivalis or to its purified cell wall components. J Immunol. 2007; 179(11):7777-90. DOI: 10.4049/jimmunol.179.11.7777. View